Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 1/20 | 0.48 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.48 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.48 |
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 8/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 8/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.36 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL947528 | 0.87 | CDK5 (0.47) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL26060781 | 0.87 | NR1I3 (0.50) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL10878132 | 0.87 | NR1I3 (0.50) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL10878141 | 0.87 | NR1I3 (0.50) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL11580475 | 0.87 | NR1I3 (0.50) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL10886068 | 0.85 | CDK5 (0.48) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL10886062 | 0.85 | CDK5 (0.48) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL28302658 | 0.85 | CDK5 (0.45) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL31620148 | 0.85 | NR1I3 (0.48) | CDK5CDK5R1NR1I3MBOAT4GRIN1 | |
| SCHEMBL27317899 | 0.81 | GRIN1 (0.55) | CDK5CDK5R1NR1I3MBOAT4GRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7972782-B2 | Steroid-activated nuclear receptors and uses therefor | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2011-07-05 | — | — | US | disclosed |
| EP-2036925-A1 | Novel steroid-activated nuclear receptors and uses therefor | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2009-03-18 | — | — | EP | disclosed |
| EP-1235861-B1 | TRANSGENIC MOUSE EXPRESSING STEROID-ACTIVATED NUCLEAR RECEPTOR | SALK INST FOR BIOLOGICAL STUDI (US) | 2008-10-22 | — | — | EP | disclosed |
| US-7413853-B2 | Modulation of metabolism of steroids and xenobiotics | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2008-08-19 | — | — | US | disclosed |
| EP-1051479-B1 | NOVEL STEROID-ACTIVATED NUCLEAR RECEPTORS AND USES THEREFOR | SALK INST FOR BIOLOGICAL STUDI (US) | 2008-07-16 | — | — | EP | disclosed |
| US-7214482-B2 | Steroid-activated nuclear receptors and uses therefor | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2007-05-08 | — | — | US | disclosed |
| US-20070026445-A1 | Novel steroid-activated nuclear receptors and uses therefor | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2007-02-01 | — | — | US | disclosed |
| US-6984773-B1 | Transgenic mice expressing a human SXR receptor polypeptide | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2006-01-10 | — | — | US | disclosed |
| US-6911537-B2 | Xenobiotic compound modulated expression systems and uses therefor | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2005-06-28 | — | — | US | disclosed |
| US-20040254135-A1 | Modulation of metabolism of steroids and xenobiotics | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2004-12-16 | — | — | US | disclosed |
| US-6809178-B2 | POLYPEPTIDE FOR USE IN THE TREATMENT OF ADDISON'S DISEASE | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2004-10-26 | — | — | US | disclosed |
| US-20030223993-A1 | Novel steroid-activated nuclear receptors and uses therefor | THE SALK INTITUTE FOR BIOLOGICAL STUDIES | 2003-12-04 | — | — | US | disclosed |
| US-20030104519-A1 | Xenobiotic compound modulated expression systems and uses therefor | SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE | 2003-06-05 | — | — | US | disclosed |
| US-20030044888-A1 | NOVEL STEROID-ACTIVATED NUCLEAR RECEPTORS AND USES THEREFOR | HOWARD HUGHES MEDICAL INSTITUTE | 2003-03-06 | — | — | US | disclosed |
| WO-2003005812-A2 | MODULATION OF METABOLISM OF STEROIDS AND XENOBIOTICS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2003-01-23 | — | — | WO | disclosed |
| EP-1051479-A4 | NOVEL STEROID-ACTIVATED NUCLEAR RECEPTORS AND USES THEREFOR | SALK INST FOR BIOLOGICAL STUDI (US) | 2002-12-04 | — | — | EP | disclosed |
| WO-2002086063-A2 | XENOBIOTIC COMPOUND MODULATED EXPRESSION SYSTEMS AND USES THEREFOR | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2002-10-31 | — | — | WO | disclosed |
| EP-1051479-A1 | NOVEL STEROID-ACTIVATED NUCLEAR RECEPTORS AND USES THEREFOR | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999035246-A9 | NOVEL STEROID-ACTIVATED NUCLEAR RECEPTORS AND USES THEREFOR | SALK INST FOR BIOLOGICAL STUDI (US) | 1999-09-30 | — | — | WO | disclosed |
| WO-1999035246-A1 | NOVEL STEROID-ACTIVATED NUCLEAR RECEPTORS AND USES THEREFOR | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1999-07-15 | — | — | WO | disclosed |